Precision Medicine

[Also: Politico uncovers more funding indiscretions from Patrick Soon-Shiong]Despite company losing $41 million in the first quarter, biotech mogul Patrick Soon-Shiong defended his company’s work and chastised what he called false reports.

New cancer test requires less DNA than previous versions.

While tests like those offered by 23andMe help patients become proactive in their healthcare, providers and the industry aren’t ready to interpret them.

Program has tapped internationally recognized bioinformatics and genomics expert to lead the effort.

Jeff Gordon & Sohn Precision Medicine Fund at Memorial Sloan Kettering Cancer Center is funded by a $200,000 grant to combat cancer in children.

The two-day event features more than 20 experts sharing insights about precision medicine in the here-and-now and the promise it holds for the future.

The upcoming event will address emerging technologies, leadership insights, challenges to overcome and practicable advice about thriving in the increasingly data-rich healthcare world.

This approval is expected to open the floodgates for more direct-to-consumer tests for disease risks.

Quality management and diagnosis and treatment systems are among top use cases for AI and cognitive computing, IDC report says.

Emails reveal details of the strings attached to Patrick Soon-Shiong’s $12 million donation to the University of Utah.